Iraq Roche Partnership to Enhance Healthcare Services

By João L. Carapinha

October 13, 2024

The article from Shafaq News highlights the renewal of the strategic Iraq Roche Partnership. This important renewal took place on September 3, 2024, following a successful year of collaboration aimed at enhancing healthcare services in Iraq.

Renewal of Partnership

The Iraqi Ministry of Health announced the renewal of its strategic partnership with Roche. This agreement aims to build on the success achieved over the past year, particularly in improving healthcare delivery across the nation.

Objectives and Initiatives

The partnership focuses on several key objectives:

  • Digital Transformation: The agreement emphasizes developing national digital tools and solutions. These innovations will improve decision-making and deliver data-driven healthcare. This initiative is a crucial part of the Ministry’s broader efforts to advance the healthcare sector through digital transformation.
  • Educational Initiatives: The partnership will continue supporting educational programs. These initiatives aim to raise awareness about early disease detection. It is vital for enhancing treatment outcomes and lessening the severity of health conditions.

Commitments and Support

  • Roche’s Commitment: Roche has confirmed its dedication to supporting the Iraqi Ministry of Health with its expertise and resources. Ayman Haj Ibrahim, Roche’s manager in Iraq, emphasized the company’s commitment to providing comprehensive care solutions for Iraqi patients.
  • Ministry’s Perspective: Iraqi Health Minister and Director General of the State Company for Marketing Drugs and Medical Appliances (Kimadia), expressed their approval. They highlighted the Ministry’s effort to develop Iraq’s healthcare sector using global expertise to meet international standards.

Signing of the Agreement

The contract renewal was signed by Dr. Ahmed Sami on behalf of the Ministry of Health and Dr. Ayman Haj Ibrahim for Roche.

Overall, the renewed strategic partnership is seen as a pivotal step towards improving healthcare services in Iraq. This collaboration leverages Roche’s global expertise and resources to drive digital transformation, enhance diagnostic capabilities, and elevate health outcomes for Iraqi citizens.

Reference url

Recent Posts

Advancing Multicenter AKI Prediction: Benefits of Collaborative Models Over Localized Approaches

By HEOR Staff Writer

April 24, 2026

New evidence demonstrates that multicenter AKI prediction models significantly outperform locally trained single-center models for forecasting postoperative acute kidney injury (AKI) after cardiac surgery. The study, published in npj Digital Medicine, analyzed 43,926 cardiac surgery c...
Advancements in Rare Disease Therapies: CHMP’s April 2026 Insights and Economic Implications

By João L. Carapinha

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommendations from its 20–23 April 2026 meeting, included a particular focus on rare disease therapies. The CHMP issued positive opinions for five new medicines, three of which carry orphan designation, alo...
Europe Pharmaceutical Access at a Critical Crossroads Amid U.S. Pricing Policies

By João L. Carapinha

April 23, 2026

Europe Pharmaceutical Access is at a “very critical point,” according to Emer Cooke, Executive Director of the European Medicines Agency (EMA). The number of new drug launches in Europe has fallen by more than a third since U.S. President Donald Trump’s “most-favored-nation” (MFN) drug pricing po...